This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Intracerebral hemorrhage (ICH) is a highly morbid form of stroke. Recent research has sought to identify pathologic processes that continue to evolve after patients present for medical care, with the hope that those delayed injuries may be effectively detected and intervened upon to improve outcomes. Our group recently reported an observation that delayed intraventricular hemorrhage (dIVH) developed in 21% of ICH subjects with no intraventricular hemorrhage (IVH) present on initial imaging.1 IVH has been characterized as an independent contributor to poor outcomes, and recognizing that delayed development of IVH was fairly common, along with the more widely recognized phenomenon of parenchymal hematoma growth, advanced it as another potential candidate for hemostatic treatments. Moreover, dIVH showed approximately the same effect size in contributing to death within 2 weeks and poor outcomes at 3 months as IVH on initial imaging, suggesting that IVH posed similar morbid consequences regardless of when it occurred.
Footnotes
Study funding: No targeted funding reported.
Disclosure: The author reports no disclosures.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
